Previous research suggests an association between hospital-volume and outcomes in high-risk 2 surgical pathologies. The association between hospital-volume and outcomes in patients with 3 isolated descending thoracic aortic aneurysms (DTAAs) and type-B thoracic aortic dissections 4 (TBAD) are conflicting. We aimed to investigate this in a literature review and meta-analysis. 5 A systematic review of the literature was performed to identify studies reporting mortality and 6 morbidity following repair (elective or emergency) of DTAA and/or TBAD using the Medline 7 and Embase Databases (2000-2015). Hospital-volume was assessed based on number of 8 patients treated per institution: low volume (1-5 cases per year), medium volume (6-10), high 9 volume (>10). Primary outcome of interest was all-cause mortality during inpatient-stay and at 10 30-days. 84 series of non-dissecting DTAA or TBAD were included in data-synthesis (4,219 11 patients; mean-age: 62 years; males: 73.5%). For all patients (emergency and elective) 12 undergoing DTAA-repair, in-hospital mortality was 8% [95% Confidence Interval (CI): 6-8%]. 13 Results were not superior in high-volume centres (8% vs. 6% vs. 11% for high, medium and 14 low-volume, respectively). Sub-analyses for emergency and elective-repairs showed no 15 significant differences. For TBAD-repairs, in the combined-population (emergency and 16 elective) results reached borderline significance (p=0.0475), favouring high volume centres 17 (6% vs. 11% vs. 14%) but this association disappeared when emergency and elective-repairs 18 were analysed separately. 9 series reported outcomes at 1 year and 5 series following DTAA 19 and 18 following TBAD treatment. No meaningful long-term comparisons were possible due 20 to lack of data. No significant associations were detected between hospital-volume and 21 subsequent mortality following DTAA or TBAD treatment. Data were heterogeneous and long-22 term results were scarcely reported. A well-designed longitudinal study of sufficient size is 23 required to inform future strategies in this area. 24 25 Word count: 3,683
INTRODUCTION 8
Thoracic aortic disease (TAD) represents a variety of diverse pathologies that affect the 9 thoracic aorta, including aneurysms, dissections, penetrating ulcers and congenital 10 abnormalities. The number of deaths attributable to TAD is increasing in the Western World 11 and so is the number of diagnoses made, possibly due to more widespread use of cross-sectional 12 imaging (1-3, 7, 8) . Minimally invasive techniques (endovascular surgery) are now frequently 13 offered as a first-line treatment in various centres. However, there is wide variability regarding 14 the use and availability of such modalities. Pathologies of the descending thoracic aorta, such 15 as descending thoracic aortic aneurysms (DTAAs) and type-B thoracic aortic dissections 16 (TBAD) are more amenable to treatment with endovascular means, both in the acute and 17 elective setting given that thoracic aortic arch reconstruction is not necessarily required in these 18 patients. Various attempts to formulate widely-acceptable consensus statements [1-3] 19 regarding the optimal management of these pathologies have identified significant evidence 20 gaps relating to the pathogenesis, type of repair (open reconstruction or endovascular repair), 21 and configuration of clinical services [4, 5] . As a result, there is still wide variability regarding 22 management strategies and outcomes, more so following the introduction of endovascular 23 means. 24 One of the most important areas of contention is that it remains unclear whether managing 1 DTAA and TBAD in high volume centres with both open and endovascular expertise will lead 2 to superior outcomes. In similar pathologies, such as type-A aortic dissection and abdominal 3 aortic aneurysm (AAA), there exists a large body of literature indicating that streamlined 4 referral pathways and treatment in high-volume centres leads to improved outcomes [6] [7] [8] . This 5 has led to a re-configuration of such services in the United States (US) and the United Kingdom 6 (UK). However, conflicting reports from regional and national retrospective datasets have 7 recently been made available regarding the results of high versus low volume centres in treating 8 DTAA and TBAD [4, 5] . The American Heart Association (AHA) guidelines for the 9 management of TAD include a level I recommendation for "evidence-based referral" of 10 patients with TAD, limiting their care to high-volume centres [9] . However, the evidence to 11 support this recommendation was level C, based mostly on expert opinion. Similarly, the 12 European Society of Cardiology (ESC) guidelines on TAD demonstrate that the evidence for 13 the management of TAD is weak compared to other cardiovascular conditions [5] . Finally, the 14 association between medium and long-term outcomes after DTAA and TBAD and hospital 15 volume also remains very unclear. 16 Following the above, the aim of this systematic literature review and subsequent meta-analysis 17 is to assess whether the volume of patients treated in a centre may affect outcome (mortality This study focuses on adult (age ≥16 years) patients with type-B thoracic aortic dissection 4 (acute and chronic) and non-dissecting thoracic aortic aneurysms (acute and chronic) without 5 an intra-abdominal component that required simultaneous treatment [10] . True thoraco-6 abdominal aneurysms with a component below the diaphragm that necessitated treatment were 7 not included as we concentrated on descending thoracic aortic pathologies. Outcomes were 8 analysed separately for each of these pathologies as well as based on the mode of presentation 9 (acute versus chronic). If a study reported outcomes for more than one pathologies or modes 10 of presentation, these were recorded separately. TAD associated with genetic syndromes and 11 infected or mycotic aneurysms were excluded. Only studies published after 01/01/2000 were included following a consensus meeting between 15 the authors, given that minimally invasive methods (hybrid and endovascular repairs for TAD) 16 were only made commercially and widely available after that point in time, together with 17 contemporary anaesthetic practices. It was felt that the inclusion of studies dating more than a 18 decade prior to the widespread adoption of endovascular techniques would not be consistent 19 with contemporary practice. The following literature databases were searched (from inception 20 to January 2015; date of search: 10/01/2015) (AS and MFB):
21
 Cochrane Central Register of Controlled Trials (CENTRAL).
22
 MEDLINE (OvidSP).
23
 Embase (OvidSP).
24
 SCOPUS.
25
The following keywords were used for the electronic search: "type B dissection" OR "thoracic 1 aortic aneurysm" AND "outcome". This identified 2,691 eligible papers from the above 2 literature databases. Further to this electronic search, reference lists of all identified papers, 3 review articles, and current treatment guidelines were searched to identify further relevant 4 articles. Overall a total of 2,712 articles were identified. The search was not limited by language 5 of publication. Following the electronic search, four authors (AS, MFB, SN, DS) independently 6 screened all titles and abstracts identified for relevance to the review aims. The following types 7 of studies were included in the data synthesis: randomised controlled trials; cohort studies 8 (prospective or retrospective); cross-sectional studies; case-control studies. Studies were only 9 included in data synthesis if they reported at least one group of patients undergoing surgery for 10 DTAA and/or TBAD and at least one of the following outcomes: inpatient mortality, 30-day 11 (peri-operative) mortality, inpatient morbidity, 30-day morbidity. Other outcomes of interest 12 included long-term mortality and morbidity but studies were not excluded on the basis of not 13 reporting these outcomes. Case reports, textbook chapters, and conference proceedings were Figure 1 describes the search 20 strategy as per PRISMA guidance [12] . In the case of missing data, investigators were contacted 21 directly to obtain records. After a minimum of two unsuccessful attempts, data were listed as 22 "missing". The overall number of patients with each type of TAD and each type of presentation (acute or 8 chronic) were recorded for each publication. The overall number of patients treated during the 9 reporting period were then divided by the number of years that data were collected for (for each (inpatient or 30-day mortality) as outcome data as applicable. Between-study heterogeneity 23 was analysed using the I 2 statistic. This describes the percentage of total variation across studies 24 that is due to heterogeneity rather than chance or random error. A value greater than 50% 25 reflects significant heterogeneity owing to real differences in study populations, protocols, 1 interventions and outcomes. A p value level <0.05 was considered statistically significant. The 2 Newcastle-Ottawa Scale [11] was used for non-randomized studies, with study quality assessed 3 by examining patient selection methods, comparability of groups and assessment of outcome.
4
Studies achieving at least seven of nine stars were considered to be of high quality. The 5 potential for publication and reporting bias was assessed by means of funnel plots.
6

RESULTS
1
All studies included in the data synthesis (as per the inclusion criteria listed above) were case-2 series (see Table 1 ). Due to the mostly retrospective nature of these series, several variables of 3 interest, such as demographics and co-morbid conditions at baseline, were missing. As a result, 4 we report outcomes based on pathology (DTAA and TBAD analysed separately) and type of 5 presentation (elective, emergency, series that have not differentiated between elective or 6 emergency repair). Meaningful analyses were only possible for in-patient mortality rates, as 7 the vast majority of series did not uniformly report on medium or short-term mortality and 8 different definitions of morbidity were used. The reported outcomes are summarized on Table   9 2 for the series eventually included in data synthesis. Overall, a total of 79 articles were were retrospective case-series. Overall, a total of 4,219 patients were included in all the series 18 (mean age was reported in 61 series: 62 years; sex was reported in 70 series: 2,868 males, 19 73.5%). 65 series reported in-hospital mortality rates but only 51 series specifically reported 20 30-day mortality rates. In-hospital mortality was therefore the primary outcome measure. We 21 did identify 34 papers that reported outcomes for thoraco-abdominal aneurysms in which 22 mention was made of patients with isolated DTAA; however, no patient level data could be 23 extracted. Long-term outcomes 26 Overall, only 9 series reported mortality and morbidity at 5 years following DTAA treatment.
1 Similar to DTAA, only 18 series reported mortality and morbidity at 1 year and 12 series 2 reported mortality and morbidity at 5 years following TBAD treatment. No meaningful 3 comparisons were possible at these time points due to lack of reported data. In this systematic review we attempted to assess the impact of institutional caseload on short-8 term mortality after repair of a descending thoracic aortic aneurysm (DTAA) or a type-B aortic 9 dissection (TBAD). Despite the fact that several series were included in the data synthesis, 10 there were no statistically significant associations between the volume of cases seen and treated 11 in each centre (per year) and subsequent short-term mortality. configuration of clinical services [4, 5] . As a result, there is still wide variability regarding 23 management strategies and outcomes.
24
In pathologies, such as type-A aortic dissection, where proximal aortic reconstruction is 25 necessary, there exists a sufficient body of literature suggesting that high-volume institutions 26 perform better; similar findings exist for treatment of abdominal aortic aneurysm (AAA), either 1 in the acute or elective setting [6] [7] [8] . AAA repair has seen a similar revolution to descending 2 TAD in recent years, following the introduction of endovascular aneurysm repair (EVAR).
3
Cardiothoracic and AAA services have subsequently seen a re-configuration in the United 4 States (US) and the UK. However, conflicting reports from regional and national retrospective Operative mortality for TEVAR was independent of hospital volume and type, whereas 4 mortality after open surgery was lower at high-volume hospitals, suggesting that TEVAR can 5 be safely performed across a spectrum of hospitals [97] . It is therefore clear that the currently 6 available literature does not provide sufficient data to allow healthcare-providers plan service 7 provision for descending thoracic aortic pathologies.
8
In that direction, we attempted to identify all series reporting outcomes from a single centre 9 after treatment of DTAA or TBAD during the last 15 years (following the introduction of newer 10 minimally invasive technologies and anaesthetic advances). We then analysed early outcomes 11 based on the mode of presentation (elective and emergency) and type of pathology. Given that 12 our primary interest were outcomes based on each centre's case-volume based on their 13 treatment strategy we did not analyse endovascular and open repair separately. The lack of 14 uniform reporting criteria and non-detailed description of the treatment modalities used in the 15 majority of these series also prohibited such an analysis. 16 One of the important observations following our systematic review is that reporting of 17 outcomes varies significantly between centres, despite the fact the clear guidelines and 18 reporting criteria have been made available more than a decade ago [13] . For example, several 19 of the series identified in the review do not report 30-day data but only provide in-hospital or 20 "peri-operative" results. A total of 65 series could be analysed for in-hospital mortality and 21 morbidity. After the peri-operative period has elapsed, reporting is of even lower quality. Only 22 9 series reported mortality and morbidity at 5 years following DTAA treatment and only 18 23 series reported mortality and morbidity at 1 year and 12 series reported mortality and morbidity 24 at 5 years following TBAD treatment. Meaningful comparisons regarding the impact of centre-25 volume are therefore not possible long-term. This is a crucial point that needs to be addressed 1 in future research, especially since follow-up pathways remain unclear. Also, as described 2 above, we cannot make any direct comparisons between endovascular and open techniques in 3 this series. Our search strategy was not designed in a way that would allow such a comparison 4 and we have not included a sufficient number of series directly comparing these two modalities.
5
Disparities in reporting outcomes and non-detailed description of the cohorts at baseline further 6 prohibit such comparisons.
7
The lack of an association between caseload and short-term mortality may have various where necessary, in a centre with sufficient experience; however, further research is mandatory 19 for commissioners to adequately plan the future of descending thoracic aortic surgery services. This study has various limitations that need be mentioned. Firstly, we did not identify any 23 randomized prospective studies, hence all data reported are based on retrospective analysed 24 cohorts of patients, which may have clearly introduced bias. Also, the aim of our search strategy 1 and subsequent meta-analysis was not to compare endovascular and open repair methods, but 2 concentrate on outcomes after treatment following the specific strategy/pathway of each centre.
3
Lack of uniform detailed description of the cohorts also prohibits meta-regression. It is also 4 important to mention that indications for intervention in TBAD were strikingly different 5 between centres; however, emergency intervention was performed for complicated dissections 6 in all cases, associated with: intractable pain or uncontrolled hypertension. Finally, we 7 identified, overall, 34 papers that reported outcomes for thoraco-abdominal aneurysms in 8 which some patients were treated for a descending thoracic aortic aneurysms. We could not 9 extract individual patient level data from these manuscripts for inclusion in our meta-analysis; 10 this may have led to further bias.
12
Overall, this study has not shown a significant association between hospital caseload and 13 subsequent short-term mortality for DTAA and TBAD. Well-designed prospective evidence is 14 urgently required to allow subsequent service planning and possible reconfiguration, taking 15 into account the recent advances in endovascular repair and reporting long-term outcomes. 
